{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:36:17Z","timestamp":1773506177942,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.amjcard.2021.02.010","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T16:18:20Z","timestamp":1613837900000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Comparison of Metoprolol Versus Carvedilol After Acute Myocardial Infarction"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7702-1913","authenticated-orcid":false,"given":"Ghaith","family":"Zaatari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan J.","family":"Fintel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haris","family":"Subacius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J","family":"Germano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Shani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9802-1851","authenticated-orcid":false,"given":"Jeffrey J.","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2021.02.010_bib0001","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/eurheartj\/ehi705","article-title":"Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction","volume":"27","author":"Gislason","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0002","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.amjcard.2012.10.026","article-title":"Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era","volume":"111","author":"Nakatani","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004190","article-title":"Relationship between \u03b2-blocker therapy at discharge and clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"5","author":"Li","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0004","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/heartjnl-2013-305137","article-title":"Benefit of \u03b2-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention","volume":"100","author":"Choo","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0005","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jacc.2015.07.047","article-title":"Effect of beta-blocker dose on survival after acute myocardial infarction","volume":"66","author":"Goldberger","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0006","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40801-016-0079-0","article-title":"Beta-blocker therapy early after myocardial infarction: a comparison between medication at hospital discharge and subsequent pharmacy-dispensed medication","volume":"3","author":"Pedersen","year":"2016","journal-title":"Drugs - Real World Outcomes"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0007","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/1060028013519591","article-title":"Beta-blockers: a review of their pharmacological and physiological diversity in hypertension","volume":"48","author":"Ripley","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0008","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ahj.2007.03.049","article-title":"Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction","volume":"154","author":"Mrdovic","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1124\/jpet.105.099903","article-title":"Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes","volume":"318","author":"Wang","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial","volume":"6","year":"1985","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0011","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(81)91101-6","article-title":"Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial","volume":"318","author":"Hjalmarson","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0012","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0013","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000446184","article-title":"Nebivolol versus carvedilol or metoprolol in patients presenting with acute myocardial infarction complicated by left ventricular dysfunction","volume":"25","author":"Ozaydin","year":"2016","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0014","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cardfail.2003.10.009","article-title":"Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?","volume":"9","author":"Bristow","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.amjcard.2018.03.004","article-title":"Effects of carvedilol versus metoprolol on platelet aggregation in patients with acute coronary syndrome: The PLATE-BLOCK Study","volume":"122","author":"Ilardi","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0016","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0895-7061(98)00017-X","article-title":"Hemodynamic differences between metoprolol and carvedilol in hypertensive patients","volume":"11","author":"Weber","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0017","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","article-title":"Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study","volume":"83","author":"Roberts","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0018","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction: mortality results","volume":"247","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0019","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction","volume":"2","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0020","first-page":"I53","article-title":"Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial","volume":"67","author":"Goldstein","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0021","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0022","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/oxfordjournals.eurheartj.a062170","article-title":"The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction","volume":"8","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0023","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0735-1097(85)80360-0","article-title":"Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity","volume":"5","author":"Olsson","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0024","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.CIR.96.1.183","article-title":"Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial","volume":"96","author":"Basu","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199347","article-title":"Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"13","author":"Watanabe","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0026","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00392-006-0317-7","article-title":"Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention\u2013the PASSAT Study","volume":"95","author":"Tolg","year":"2006","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0027","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.amjcard.2017.07.036","article-title":"Meta-analysis comparing metoprolol and carvedilol on mortality benefits in patients with acute myocardial infarction","volume":"120","author":"Li","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2021.02.010_bib0028","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.amjcard.2012.11.031","article-title":"Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol)","volume":"111","author":"DiNicolantonio","year":"2013","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914921001557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914921001557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:37:40Z","timestamp":1757572660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914921001557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":28,"alternative-id":["S0002914921001557"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2021.02.010","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Metoprolol Versus Carvedilol After Acute Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2021.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}